Cargando…
Diabetic neuropathy: a risk factor for severe COVID-19?
Autores principales: | Pitocco, Dario, Viti, Luca, Santoliquido, Angelo, Tartaglione, Linda, Di Leo, Mauro, Bianchi, Antonio, Caputo, Salvatore, Pontecorvi, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856617/ https://www.ncbi.nlm.nih.gov/pubmed/33533971 http://dx.doi.org/10.1007/s00592-020-01658-7 |
Ejemplares similares
-
SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?
por: Pitocco, Dario, et al.
Publicado: (2020) -
Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence?
por: Pitocco, Dario, et al.
Publicado: (2020) -
Diabetes and severity of COVID-19: What is the link?
por: Pitocco, D., et al.
Publicado: (2020) -
Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond
por: Tosti, Giulia, et al.
Publicado: (2023) -
Type 1 diabetes recurrence after SARS‐CoV‐2 infection in a subject with pancreas transplantation
por: Popolla, Valentina, et al.
Publicado: (2022)